Integrated Diagnostics Inform Diagnostics offers a comprehensive, multidisciplinary pathology and molecular diagnostics platform including dermatopathology, gastrointestinal, hematopathology, neuropathology, breast, genitourinary pathology and Covid testing, enabling health systems to consolidate workflows and pursue bundled service agreements.

National Lab Footprint State‑of‑the‑art laboratories in Boston, Dallas, New York City and Phoenix provide nationwide coverage with scalable capacity and consistent turnaround, supporting partnerships with multi‑site health systems.

Acquisition Advantage As a Fulgent Genetics company since 2022, Inform Diagnostics gains access to a broader genetics ecosystem, opening cross‑sell opportunities for advanced molecular testing and integrated diagnostics to existing pathology customers.

Digital Partnering A Mazik Global collaboration to improve provider communications and patient engagement indicates openness to digital workflows and CRM integrations, presenting opportunities for sales to offer enhanced care coordination tools.

Growth and Compliance Commercial growth initiatives and past regulatory matters underscore the value of robust compliance and revenue cycle enhancements, creating sales angles around governance, billing integrity and transparent pricing for pathology services.